CTLA4 and rheumatoid arthritis: Abatacept, a fusion protein consisting of the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 and a modified Fc portion of human IgG1, is approved for rheumatoid arthritis (RA).